USANA Health Sciences Reports Strong Q2 Sales Growth

USANA Health Sciences Inc ( (USNA) ) has released its Q2 earnings. Here is a breakdown of the information USANA Health Sciences Inc presented to its investors.

USANA Health Sciences Inc. is a company that develops and manufactures high-quality nutritional supplements, functional foods, and personal care products, primarily operating in the health and wellness sector with a unique focus on direct selling.

In its second-quarter earnings report for 2025, USANA Health Sciences reported a notable 11% increase in net sales year-over-year, reaching $236 million. Despite this growth, net earnings saw a slight decline to $9.7 million compared to the previous year. The company also reiterated its fiscal year 2025 outlook, maintaining confidence in its strategic direction.

Key financial metrics from the report include an adjusted diluted EPS of $0.74, marking a 36% increase from the previous year, and an adjusted EBITDA of $30 million, up 13%. The company also highlighted its strategic initiatives, such as the rollout of enhanced sales incentives and the adoption of ‘Brand Partner’ terminology for its direct sales force. Additionally, USANA’s Hiya business, a direct-to-consumer segment, reported strong growth, supported by a new partnership with Disney.

USANA’s regional performance showed mixed results, with a decline in active customers in the Asia Pacific and Americas and Europe regions. However, the company ended the quarter with a strong balance sheet, including $151 million in cash and no debt, and continued its share repurchase program.

Looking ahead, USANA remains optimistic about its growth prospects, anticipating consolidated net sales growth of 8% to 17% for the fiscal year 2025. The company plans to continue executing its comprehensive commercial strategy to drive sustainable sales and customer growth, despite the fluid operating environment.